Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 527-541
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.527
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.527
Table 1 Sources of exosomes and their roles in ulcerative colitis
Exosomes source | Pivotal molecules | Role of the exosomes | Conclusion | Ref. |
Stem cell | miR-378a-5p | Inhibiting pyroptosis through NLRP3/caspase-1 signaling | Beneficial | [71] |
Stem cell | miR-539-5p | Inhibiting pyroptosis through NLRP3/caspase-1 signaling | Beneficial | [72] |
Stem cell | miRNA | Suppressing pyroptosis | Beneficial | [73] |
Stem cell | miR-203a-3p.2 | Suppressing macrophage pyroptosis induced by caspase11/4 | Beneficial | [74] |
Stem cell | NA | Regulating the Treg population | Beneficial | [75] |
Stem cell | NA | Modulating the gut metagenomics-metabolomics-farnesoid X receptor axis | Beneficial | [76] |
Stem cell | NA | Polarizing M2b macrophages | Beneficial | [77] |
Stem cell | miR-146a | Inhibiting SUMO1 expression and its binding to β-catenin | Beneficial | [78] |
Stem cell | miR-216a-5p | Inducing macrophage M2 polarization by regulating the HMGB1/TLR4/NF-κB signaling pathway | Beneficial | [79] |
Stem cell | NA | Regulating the Th17/Treg balance | Beneficial | [80] |
Stem cell | NA | Repairing intestinal barrier via TSG-6 | Beneficial | [81] |
Stem cell | miR-125a, miR-125b | Repressing Th17 cell differentiation | Beneficial | [82] |
Stem cell | NA | Limiting intestinal epithelial cells reactive oxygen species accumulation and DNA damage through HIF-1α | Beneficial | [83] |
Stem cell | miR-181a | Improving gut microbiota composition, barrier function, and inflammatory status | Beneficial | [84] |
Stem cell | NA | Suppressing inflammation | Beneficial | [85] |
Stem cell | NA | Modulating Th1/Th17 and Treg cell responses | Beneficial | [86] |
Stem cell | NA | Attenuating inflammation, oxidative stress and apoptosis | Beneficial | [87] |
Stem cell | NA | Stimulating epithelial repair and decreasing epithelial apoptosis | Beneficial | [88] |
Stem cell | NA | Modulating the expression of IL-7 in macrophages | Beneficial | [89] |
Stem cell | NA | Downregulating intestine ferroptosis | Beneficial | [90] |
Melatonin and stem cell | NA | Suppressing inflammation, oxidative stress, apoptosis, and fibrosis | Beneficial | [91] |
Dendritic Cell | miR-146a | Targeting Traf6, IRAK-1, and NLRP3 in macrophages | Beneficial | [92] |
Dendritic cell | NA | Preventing colon damage | Beneficial | [93] |
Dendritic cell | NA | Downregulating the expression of IL-2, IFN-γ and TNF-α | Beneficial | [94] |
Dendritic cell | NA | Carrying drug to dendritic cell | Beneficial | [95] |
M2 macrophage | miR-590-3p | Suppressing LATS1 and activating the YAP/β-catenin signaling | Beneficial | [96] |
M1 macrophage | MiR-21a-5p | Decreasing E-cadherin and subsequent ILC2 activation | Unfavorable | [97] |
Intestinal | NA | Promoting wound healing | Beneficial | [98] |
Visceral adipose tissue | miR-155 | Promoting macrophage M1 polarization | Unfavorable | [99] |
Serum | NA | Inhibiting MCP-1 and MIP-1α expression via NLRP12-Notch signaling pathway | Beneficial | [100] |
Serum | Proteins | Implicating macrophage activation | NA | [101] |
Helicobacter pylori | NA | Aggravating intestinal epithelium barrier dysfunction by facilitating Claudin-2 expression | Unfavorable | [102] |
Milk | NA | Suppressing inflammation | Beneficial | [103] |
Cow and human milk | miRNA-320, 375, and Let-7 | Downregulating DNA methyltransferase 1 (DNMT1) and DNMT3 | Beneficial | [104] |
Bovine colostrum | NA | Suppressing inflammation and oxidative stress | Beneficial | [105] |
Table 2 Sources of exosomes and their roles in NOD-like receptor family pyrin domain containing 3 inflammasome regulation
Exosomes source | Pivotal molecules | Role of the exosomes | Ref. |
Stem cell | miR-378a-5p | Inhibiting NLRP3 inflammasome activation | [71] |
Stem cell | miR-539-5p | Inhibiting NLRP3 inflammasome activation | [72] |
Stem cell | NA | Inhibiting NLRP3 inflammasome activation | [73] |
Stem cell | miR-17 | Inhibiting NLRP3 inflammasome activation by targeting TXNIP | [106] |
Stem cell | NA | Inhibiting NLRP3 inflammasome activation by down-regulating ROS levels | [107] |
Stem cell | NA | Inhibiting TLR4-NLRP3-mediated pyroptosis | [108] |
Plasma | NA | Inhibiting pyroptosis through the TLR4/NF-κB pathway | [109] |
Stem cell | NA | Inhibiting NLRP3 inflammasome-mediated pyroptosis by promoting AMPK-dependent autophagic flux | [110] |
Stem cell | circHIPK3 | Inhibiting pyroptosis by down-regulating miR-421 to increase FOXO3A expression | [111] |
Stem cell | miRNA Let-7 | Inhibiting NLRP3 inflammasome activation by down-regulating ROS levels | [112] |
Stem cell | miR-188-3p | Targeting NLRP3 | [113] |
Stem cell | NA | Inhibiting the tumor suppressor Rb1-mediated NLRP3 inflammasome | [114] |
Stem cell | NA | Inhibiting pyroptosis through the TLR4 pathway | [115] |
Cancer cells | miR-21 | Repressing PTEN and BRCC3 to facilitate NLRP3 phosphorylation | [116] |
Stem cell | circ_003564 | Attenuating inflammasome-related pyroptosis | [117] |
Stem cell | miR-100-5p | Inhibiting the FOXO3A/NLRP3 pathway | [118] |
Stem cell | miR-17-5p | Suppressing TXNIP-NLRP3 inflammasome | [119] |
Pericyte | circEhmt1 | Upregulating NFIA levels to suppress NLRP3-mediated inflammasome formation | [120] |
B cells | miR-BART15 | Targeting the miR-223 binding site in the NLRP3 3′-untranslated region | [121] |
Stem cell | NA | Suppressing NLRP3 inflammasome activation | [122] |
Stem cell | NA | Suppressing NLRP3 inflammasome activation | [123] |
Stem cell | NA | Suppressing NLRP3 inflammasome activation | [124] |
Stem cell | NA | Regulating pyroptosis via the miR-146a-5p-TRAF6 axis | [125] |
M2 macrophage | NA | Suppressing the ROS/NLRP3 pathway | [126] |
Stem cell | NA | Attenuating inflammasome-related pyroptosis | [127] |
Cancer cells | NA | Suppressing NLRP3 inflammasome activation | [128] |
Stem cell | miR-23b | Attenuating inflammasome-related pyroptosis | [129] |
Stem cell | miR-223-3p | Targeting NLRP3 | [130] |
Stem cell | NA | Suppressing NLRP3 inflammasome activation | [131] |
Stem cell | NA | Modulating miR-126 via targeting HMGB1 | [132] |
Plasma | NA | Promoting the autophagic degradation of NLRP3 | [133] |
Stem cell | miR-223 | Downregulating NLRP3 expression | [134] |
Dendritic cell | NA | Downregulating NLRP3 expression | [135] |
M2 macrophage | microRNA-148a | Inhibiting the TLR4/NF-κB/NLRP3 pathway | [136] |
Salivary | miR-223-3p | Attenuating inflammasome-related pyroptosis | [137] |
Neutrophils | miR-30d-5p | Upregulating NLRP3 expression through the NF-κB pathway | [138] |
Cancer cells | TRIM59 | Inducing the ubiquitination of ABHD5 to activate the NLRP3 inflammasome activation | [139] |
Epithelium cells | NA | Upregulating the NLRP3 inflammasome | [140] |
Serum | NA | Activating the NLRP3 inflammasome | [141] |
Plasma | NA | Triggering NLRP3-dependent pyroptosis | [142] |
Plasma | NA | Triggering NLRP3 inflammasome | [143] |
Plasma | NA | Activating the NLRP3 inflammasome | [144] |
Serum | NA | Inhibiting the NF-κB/NLRP3 pathway | [145] |
Plasma | miRNA-223 | Inhibiting NLRP3 | [146] |
Renal tissues | NA | Suppressing NLRP3 activation | [147] |
- Citation: Li X, Ji LJ, Feng KD, Huang H, Liang MR, Cheng SJ, Meng XD. Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome. World J Gastroenterol 2024; 30(6): 527-541
- URL: https://www.wjgnet.com/1007-9327/full/v30/i6/527.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i6.527